Inhibition of lncRNA H19/miR-370-3p pathway mitigates neuronal apoptosis in an in vitro model of spinal cord injury (SCI)
Translational Neuroscience, 2021 · DOI: https://doi.org/10.1515/tnsci-2021-0013 · Published: January 27, 2021
Simple Explanation
Spinal cord injury (SCI) often leads to limb dysfunction, and current treatments are not always effective. Gene therapy is being explored as a new research direction. This study investigates the role of lncRNA H19 and miR-370-3p in SCI, showing that inhibiting lncRNA H19 reduces nerve cell death in a lab model. The research suggests that gene therapy targeting this pathway could potentially be used to treat SCI in the future.
Study Duration
7 weeks
Participants
12 male Sprague-Dawley rats
Evidence Level
In vitro study
Key Findings
- 1SCI leads to increased lncRNA H19 and decreased miR-370-3p expression.
- 2Inhibiting lncRNA H19 reverses LPS-induced changes, such as decreased cell viability and increased apoptosis.
- 3LncRNA H19 inhibition can block the NF-κB pathway through miR-370-3p upregulation.
Research Summary
This study investigates the role of lncRNA H19 and miR-370-3p in spinal cord injury (SCI) using an in vitro model. The results indicate that inhibiting lncRNA H19 can mitigate spinal neuron apoptosis, potentially through the upregulation of miR-370-3p and blockage of the NF-κB pathway. The findings suggest that targeting the lncRNA H19/miR-370-3p pathway could offer a new therapeutic strategy for SCI.
Practical Implications
Therapeutic Target
LncRNA H19/miR-370-3p pathway can be a potential target for gene therapy in SCI.
Clinical Applications
Provides possibility for clinical use of gene therapy.
Diagnostic Marker
LncRNA H19 could serve as a marker of SCI diagnosis and poor prognosis.
Study Limitations
- 1[object Object]
- 2[object Object]
- 3[object Object]